ProteinLogic has developed a novel technology platform (ImmiPrint®) focused on the diagnosis of tuberculosis (TB). Along with HIV/AIDS, TB is the most significant infectious disease worldwide. Early and accurate diagnosis is essential for its control.
The ImmiPrint® platform has the potential to deliver an effective blood-based TB diagnostic, and to provide information on disease progression. The test may also be able to predict which individuals are likely to respond to anti-microbial therapy.
Company Details
- Employees
- 1
- Address
- 42 Newmarket Road, Cambridge,cambridgeshire Cb5 8ep,united Kingdom
- in****@****gic.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- proteinlogic.com
- Keywords
- London.
- HQ
- Cambridge, Cambridgeshire
Proteinlogic Ltd Questions
Proteinlogic Ltd's website is proteinlogic.com
Proteinlogic Ltd's LinkedIn profile is https://uk.linkedin.com/company/proteinlogic-ltd
Proteinlogic Ltd has
1 employees.
View email and phone details for 1
employees at Proteinlogic Ltd.
Proteinlogic Ltd's industry is
Biotechnology Research
Proteinlogic Ltd's top competitors are
Technotitia,
Tamarind Bio,
Amazing Gut,
Sirona Biochem Corp.,
Purcell Bio,
310.ai,
Proteinlogic,
Neurosnap Inc.,
Via Scientific, Inc.,
Microforge Polymers.
Proteinlogic Ltd's support email address is info@proteinlogic.com
Proteinlogic Ltd's categories are Biotechnology Research
